Gouaref Inès, Detaille Dominique, Wiernsperger Nicolas, Khan Naim Akhtar, Leverve Xavier, Koceir Elhadj-Ahmed
Bioenergetics and Intermediary Metabolism team, Laboratory of Biology and Organism Physiology, Biological Sciences Institute, University of Sciences and Technology Houari Boumediene, BP 32, ElAlia, Algiers, Algeria.
Université de Bordeaux, Rhythmology and Heart Modeling Institute, Bordeaux, France.
PLoS One. 2017 Feb 21;12(2):e0172053. doi: 10.1371/journal.pone.0172053. eCollection 2017.
While metformin (MET) is the most widely prescribed antidiabetic drug worldwide, its beneficial effects in Psammomys obesus (P. obesus), a rodent model that mimics most of the metabolic features of human diabetes, have not been explored thoroughly. Here, we sought to investigate whether MET might improve insulin sensitivity, glucose homeostasis, lipid profile as well as cellular redox and energy balance in P. obesus maintained on a high energy diet (HED).
P. obesus gerbils were randomly assigned to receive either a natural diet (ND) consisting of halophytic plants (control group) or a HED (diabetic group) for a period of 24 weeks. MET (50 mg/kg per os) was administered in both animal groups after 12 weeks of feeding, i.e., the time required for the manifestation of insulin resistance in P. obesus fed a HED. Parallel in vitro experiments were conducted on isolated hepatocytes that were shortly incubated (30 min) with MET and energetic substrates (lactate + pyruvate or alanine, in the presence of octanoate).
In vivo, MET lowered glycemia, glycosylated haemoglobin, circulating insulin and fatty acid levels in diabetic P. obesus. It also largely reversed HED-induced hepatic lipid alterations. In vitro, MET increased glycolysis but decreased both gluconeogenesis and ketogenesis in the presence of glucogenic precursors and medium-chain fatty acid. Importantly, these changes were associated with an increase in cytosolic and mitochondrial redox states along with a decline in respiration capacity.
MET prevents the progression of insulin resistance in diabetes-prone P. obesus, possibly through a tight control of gluconeogenesis and fatty acid β-oxidation depending upon mitochondrial function. While the latter is increasingly becoming a therapeutic issue in diabetes, the gut microbiota is another promising target that would need to be considered as well.
虽然二甲双胍(MET)是全球处方最广泛的抗糖尿病药物,但其在肥胖沙鼠(Psammomys obesus,P. obesus)中的有益作用尚未得到充分研究,肥胖沙鼠是一种模拟人类糖尿病大部分代谢特征的啮齿动物模型。在此,我们试图研究MET是否可以改善高能量饮食(HED)喂养的肥胖沙鼠的胰岛素敏感性、葡萄糖稳态、脂质谱以及细胞氧化还原和能量平衡。
将肥胖沙鼠随机分为两组,一组给予由盐生植物组成的天然饮食(ND,对照组),另一组给予HED(糖尿病组),为期24周。喂养12周后,即肥胖沙鼠喂食HED后出现胰岛素抵抗所需的时间,在两组动物中均给予MET(50mg/kg口服)。对分离的肝细胞进行平行的体外实验,将其与MET和能量底物(乳酸+丙酮酸或丙氨酸,在辛酸存在下)短暂孵育(30分钟)。
在体内,MET降低了糖尿病肥胖沙鼠的血糖、糖化血红蛋白、循环胰岛素和脂肪酸水平。它还在很大程度上逆转了HED诱导的肝脏脂质改变。在体外,在存在生糖前体和中链脂肪酸的情况下,MET增加了糖酵解,但降低了糖异生和酮体生成。重要的是,这些变化与细胞溶质和线粒体氧化还原状态的增加以及呼吸能力的下降有关。
MET可预防易患糖尿病的肥胖沙鼠胰岛素抵抗的进展,可能是通过严格控制糖异生和脂肪酸β氧化,这取决于线粒体功能。虽然后者在糖尿病中越来越成为一个治疗问题,但肠道微生物群也是一个有前景的靶点,也需要加以考虑。